'Strong synergies': IDT Biologika expands SK bioscience's global reach into new projects

BOSTON — SK bioscience’s acquisition of German contract manufacturer IDT Biologika last year was a strategic play to globalize its drug manufacturing footprint and tap into IDT’s century-old client base.